Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • yaximik
    Senior Member
    • Apr 2011
    • 199

    #1

    GPU vs Phi: advice needed

    A while ago I asked a general question about practical usability of GPU- and Phi- based platforms for multithread-enabled bioinformatics applications. I am aware of previously held discussion here. My understanding that there was not much experience accumulated yet with use of these systems to outline the differences in capabilities. I wonder if there is more of such experience now. Basically I have choice to obtain a RHEL 6 server equipped with 2 8-core Xeon E5 2690 and 4 either K20x GPU or 60-core Xeon Phi coprocessors. The price is about the same. Microway engineers advise to go with GPU as there are more applications developed.
    As I am not programmer, rather a self-educating end user, my question is which configuration will be more usable in the current universe of bioinformatis applications without code modifications? Please forgive if my questions sound naive. For example, very likely I will not be able to take advantage of thousands of cores with the GPU configuration when using GNU parallel or multithreading in BWA or blast+ without significant investment in code modification. But what about Phi - can I take immediate advantage of 240 cores with the Phi configuration?
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    We had a recent discussion on this with input from Rick Westerman: http://seqanswers.com/forums/showthread.php?t=20931

    I/O and memory needs of most NGS applications make use of either the GPU/Phi impractical at this time. Unless you have a use case identified for either the GPU/Phi, you may be better off putting that money towards upgrade of some other components.
    Last edited by GenoMax; 09-11-2013, 06:47 AM.

    Comment

    • ymc
      Senior Member
      • Mar 2010
      • 496

      #3
      While GPU-based NGS applications are not that many, Phi-based NGS applications are basically nil (Let me know if you know of one). soap3-dp is a GPU-based application that you can use to replace bwa.

      I think you will only pick Phi if you have some floating point application that is based on some old code optimized for x86. There aren't many such application for NGS. Therefore it makes no sense to use Phi at all.

      Comment

      • ymc
        Senior Member
        • Mar 2010
        • 496

        #4
        Originally posted by GenoMax View Post
        We had a recent discussion on this with input from Rick Westerman: http://seqanswers.com/forums/showthread.php?t=20931

        I/O and memory needs of most NGS applications make use of either the GPU/Phi impractical at this time. Unless you have a use case identified for either the GPU/Phi, you may be better off putting that money towards upgrade of some other components.
        If you have some application that make use of floating point calculations a lot, then the value of GPU will show. For example, I have a CUDA program that calculates pairwise familial relationships between my samples.

        Another way of thinking is that using GPU can make your system more compact. For example, you can run soap3-dp on a GPU and then do other stuff with your CPUs. In this sense, your computations per one computer case volume will be higher than without GPU.

        Comment

        • yaximik
          Senior Member
          • Apr 2011
          • 199

          #5
          I missed the most recent discussion, thanks for the link, very useful. Also thanks a lot for other useful inputs.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Yesterday, 11:13 AM
          0 responses
          13 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, Yesterday, 10:48 AM
          0 responses
          12 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          32 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          40 views
          0 reactions
          Last Post SEQadmin2  
          Working...